Sponsor Pipeline

Hellenic Institute for the Study of Sepsis Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
3
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2/3
1
Phase 2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06294600 Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) Community-acquired Pneumonia Recruiting
NCT05909683 Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe… Sepsis Active, Not Recruiting
Phase 2/3
NCT05926505 Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome Post-Acute COVID-19 Syndrome Recruiting
Phase 2
NCT06694701 Emapalumab Treatment For Anticipated Clinical Benefit In Sepsis Driven By The… Sepsis Active, Not Recruiting
Not specified
NCT07073456 Viscoelastic Coagulation for Early Sepsis Detection Infection Recruiting
NCT06608849 The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable… Pulmonary Complications Recruiting
NCT06601998 Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung… Pneumonia, Community-Acquired Recruiting
Disease Areas
Heart Disease (1)
Get alerts when Hellenic Institute for the Study of Sepsis's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free